DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Abstract

Inhibitors of the voltage-gated sodium channel NaV1.7 are being investigated as pain therapeutics due to compelling human genetics. We previously identified NaV1.7-inhibitory peptides GpTx-1 and JzTx-V from tarantula venom screens. Potency and selectivity were modulated through attribute-based positional scans of native residues via chemical synthesis. In this paper, we report JzTx-V lead optimization to identify a pharmacodynamically active peptide variant. Molecular docking of peptide ensembles from NMR into a homology model-derived NaV1.7 structure supported prioritization of key residues clustered on a hydrophobic face of the disulfide-rich folded peptide for derivatization. Replacing Trp24 with 5-Br- Trp24 identified lead peptides with activity in electrophysiology assays in engineered and neuronal cells. 5-Br-Trp24 containing peptide AM-6120 was characterized in X-ray crystallography and pharmacokinetic studies and blocked histamine-induced pruritis in mice after subcutaneous administration, demonstrating systemic NaV1.7-dependent pharmacodynamics. Our data suggests a need for high target coverage based on plasma exposure for impacting in vivo end points with selectivity-optimized peptidic NaV1.7 inhibitors.

Authors:
ORCiD logo [1];  [1];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [3];  [3];  [2];  [1];  [2];  [2];  [1];  [1]; ORCiD logo [1]
  1. Amgen Inc., Thousand Oaks, CA (United States)
  2. Amgen Inc., Cambridge, MA (United States)
  3. Amgen Inc., South San Francisco, CA (United States)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
OSTI Identifier:
1483893
Grant/Contract Number:  
W-31-109-Eng-38
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Medicinal Chemistry
Additional Journal Information:
Journal Volume: 61; Journal Issue: 21; Journal ID: ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; Modification; Peptides and proteins; Structure activity relationship; Rodent models; Selectivity

Citation Formats

Wu, Bin, Murray, Justin K., Andrews, Kristin L., Sham, Kelvin, Long, Jason, Aral, Jennifer, Ligutti, Joseph, Amagasu, Shanti, Liu, Dong, Zou, Anruo, Min, Xiaoshan, Wang, Zhulun, Ilch, Christopher P., Kornecook, Thomas J., Lin, Min-Hwa Jasmine, Be, Xuhai, Miranda, Les P., Moyer, Bryan D., and Biswas, Kaustav. Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis. United States: N. p., 2018. Web. doi:10.1021/acs.jmedchem.8b00736.
Wu, Bin, Murray, Justin K., Andrews, Kristin L., Sham, Kelvin, Long, Jason, Aral, Jennifer, Ligutti, Joseph, Amagasu, Shanti, Liu, Dong, Zou, Anruo, Min, Xiaoshan, Wang, Zhulun, Ilch, Christopher P., Kornecook, Thomas J., Lin, Min-Hwa Jasmine, Be, Xuhai, Miranda, Les P., Moyer, Bryan D., & Biswas, Kaustav. Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis. United States. https://doi.org/10.1021/acs.jmedchem.8b00736
Wu, Bin, Murray, Justin K., Andrews, Kristin L., Sham, Kelvin, Long, Jason, Aral, Jennifer, Ligutti, Joseph, Amagasu, Shanti, Liu, Dong, Zou, Anruo, Min, Xiaoshan, Wang, Zhulun, Ilch, Christopher P., Kornecook, Thomas J., Lin, Min-Hwa Jasmine, Be, Xuhai, Miranda, Les P., Moyer, Bryan D., and Biswas, Kaustav. Mon . "Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis". United States. https://doi.org/10.1021/acs.jmedchem.8b00736. https://www.osti.gov/servlets/purl/1483893.
@article{osti_1483893,
title = {Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis},
author = {Wu, Bin and Murray, Justin K. and Andrews, Kristin L. and Sham, Kelvin and Long, Jason and Aral, Jennifer and Ligutti, Joseph and Amagasu, Shanti and Liu, Dong and Zou, Anruo and Min, Xiaoshan and Wang, Zhulun and Ilch, Christopher P. and Kornecook, Thomas J. and Lin, Min-Hwa Jasmine and Be, Xuhai and Miranda, Les P. and Moyer, Bryan D. and Biswas, Kaustav},
abstractNote = {Inhibitors of the voltage-gated sodium channel NaV1.7 are being investigated as pain therapeutics due to compelling human genetics. We previously identified NaV1.7-inhibitory peptides GpTx-1 and JzTx-V from tarantula venom screens. Potency and selectivity were modulated through attribute-based positional scans of native residues via chemical synthesis. In this paper, we report JzTx-V lead optimization to identify a pharmacodynamically active peptide variant. Molecular docking of peptide ensembles from NMR into a homology model-derived NaV1.7 structure supported prioritization of key residues clustered on a hydrophobic face of the disulfide-rich folded peptide for derivatization. Replacing Trp24 with 5-Br- Trp24 identified lead peptides with activity in electrophysiology assays in engineered and neuronal cells. 5-Br-Trp24 containing peptide AM-6120 was characterized in X-ray crystallography and pharmacokinetic studies and blocked histamine-induced pruritis in mice after subcutaneous administration, demonstrating systemic NaV1.7-dependent pharmacodynamics. Our data suggests a need for high target coverage based on plasma exposure for impacting in vivo end points with selectivity-optimized peptidic NaV1.7 inhibitors.},
doi = {10.1021/acs.jmedchem.8b00736},
journal = {Journal of Medicinal Chemistry},
number = 21,
volume = 61,
place = {United States},
year = {Mon Oct 22 00:00:00 EDT 2018},
month = {Mon Oct 22 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 15 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

The Role of Science in Addressing the Opioid Crisis
journal, July 2017

  • Volkow, Nora D.; Collins, Francis S.
  • New England Journal of Medicine, Vol. 377, Issue 4
  • DOI: 10.1056/NEJMsr1706626

The pain drain
journal, July 2016


NaV1.7 as a pain target – From gene to pharmacology
journal, April 2017


The NaV1.7 sodium channel: from molecule to man
journal, December 2012

  • Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.
  • Nature Reviews Neuroscience, Vol. 14, Issue 1
  • DOI: 10.1038/nrn3404

Recent progress in sodium channel modulators for pain
journal, August 2014

  • Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 16
  • DOI: 10.1016/j.bmcl.2014.06.038

Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
journal, May 2015

  • de Lera Ruiz, Manuel; Kraus, Richard L.
  • Journal of Medicinal Chemistry, Vol. 58, Issue 18
  • DOI: 10.1021/jm501981g

ProTx-II, a Selective Inhibitor of Na V 1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors
journal, August 2008

  • Schmalhofer, William A.; Calhoun, Jeffrey; Burrows, Rachel
  • Molecular Pharmacology, Vol. 74, Issue 5
  • DOI: 10.1124/mol.108.047670

The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant
journal, March 2017


Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
journal, January 2017

  • Deuis, Jennifer R.; Dekan, Zoltan; Wingerd, Joshua S.
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep40883

Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor
journal, January 2017

  • Flinspach, M.; Xu, Q.; Piekarz, A. D.
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep39662

Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the Na V 1.7 Sodium Channel
journal, February 2015

  • Murray, Justin K.; Ligutti, Joseph; Liu, Dong
  • Journal of Medicinal Chemistry, Vol. 58, Issue 5
  • DOI: 10.1021/jm501765v

Sustained inhibition of the Na V 1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1
journal, November 2015

  • Murray, Justin K.; Biswas, Kaustav; Holder, J. Ryan
  • Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 21
  • DOI: 10.1016/j.bmcl.2015.06.033

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the Na V 1.7 Inhibitory Peptide GpTx-1
journal, March 2016


Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain
journal, March 2016


Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3
journal, August 2015


Closing In on the Resting State of the Shaker K+ Channel
journal, October 2007


Docking unbound proteins using shape complementarity, desolvation, and electrostatics
journal, April 2002

  • Chen, Rong; Weng, Zhiping
  • Proteins: Structure, Function, and Genetics, Vol. 47, Issue 3
  • DOI: 10.1002/prot.10092

Common Molecular Determinants of Tarantula Huwentoxin-IV Inhibition of Na+ Channel Voltage Sensors in Domains II and IV
journal, August 2011

  • Xiao, Yucheng; Jackson, James O.; Liang, Songping
  • Journal of Biological Chemistry, Vol. 286, Issue 31
  • DOI: 10.1074/jbc.M111.246876

Spider-venom peptides that target voltage-gated sodium channels: Pharmacological tools and potential therapeutic leads
journal, September 2012


Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution
journal, February 2017


Structure of the Na v 1.4-β1 Complex from Electric Eel
journal, July 2017


Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin
journal, November 2008


Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (μ-TRTX-Hh2a)
journal, August 2013

  • Minassian, Natali A.; Gibbs, Alan; Shih, Amy Y.
  • Journal of Biological Chemistry, Vol. 288, Issue 31
  • DOI: 10.1074/jbc.M113.461392

Racemic and Quasi-Racemic X-ray Structures of Cyclic Disulfide-Rich Peptide Drug Scaffolds
journal, August 2014

  • Wang, Conan K.; King, Gordon J.; Northfield, Susan E.
  • Angewandte Chemie International Edition, Vol. 53, Issue 42
  • DOI: 10.1002/anie.201406563

Engineering Antibody Reactivity for Efficient Derivatization to Generate Na V 1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates
journal, August 2017


Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na V 1.7
journal, May 2017

  • Kornecook, Thomas J.; Yin, Ruoyuan; Altmann, Stephen
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 362, Issue 1
  • DOI: 10.1124/jpet.116.239590

Sulfonamides as Selective Na V 1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
journal, April 2017


Analysis of accessible surface of residues in proteins
journal, July 2003

  • Lins, Laurence; Thomas, Annick; Brasseur, Robert
  • Protein Science, Vol. 12, Issue 7
  • DOI: 10.1110/ps.0304803

The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Na v 1.7
journal, September 2017

  • Wright, Zoë V. F.; McCarthy, Stephen; Dickman, Rachael
  • Journal of the American Chemical Society, Vol. 139, Issue 37
  • DOI: 10.1021/jacs.7b06506

Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain
journal, September 2014


Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment
journal, December 2012

  • Ingwersen, Steen H.; Khurana, Manoj; Madabushi, Rajanikanth
  • The Journal of Clinical Pharmacology, Vol. 52, Issue 12
  • DOI: 10.1177/0091270011430504

XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

How good are my data and what is the resolution?
journal, June 2013

  • Evans, Philip R.; Murshudov, Garib N.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7
  • DOI: 10.1107/S0907444913000061

The CCP4 suite programs for protein crystallography
journal, September 1994


A modified ACORN to solve protein structures at resolutions of 1.7 Å or better
journal, October 2005

  • Jia-xing, Yao; Woolfson, M. M.; Wilson, K. S.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 61, Issue 11
  • DOI: 10.1107/S090744490502576X

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997

  • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
  • DOI: 10.1107/S0907444996012255

Works referencing / citing this record:

Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins
journal, September 2020